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ABSTRACT 
Mucins in mucus are particularly rich in an indispensable amino acid, 
threonine, and their continuous synthesis and secretion represent a major 
use of dietary threonine. In piglets, the small intestine is particularly sensitive 
to a low threonine intake resulting in compromised mucin production. Other 
epithelial tissues also synthesize large amounts of mucin but their impact on 
threonine requirement is not as well known. Yucatan mini-piglets were fed 
test diets with different threonine intakes and various tissues were analyzed 
for protein synthesis. The threonine intake at which maximal protein 
synthesis was reached was lower for mucin-producing tissues, suggesting 
mucin-producing tissues are conserved when dietary threonine is limiting, 
compared to muscle, liver and kidney. So if neonates are on a marginal 
threonine intake, then growth and the functions of other vital tissues are 
likely compromised at the expense of maintenance of the mucus layer. 
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Chapter 1 : LITERATURE REVIEW 
1.1 Introduction 
Although the gut comprises only 14% of whole body protein (McNurlan & 
Garlick, 1980), there is substantial amino acid metabolism in the gut 
(Baracos, 2004). The total amount of protein synthesized per day in liver, 
stomach, small and large intestine is equal to 43% of the total of whole body 
(McNurlan & Garlick, 1980). The high growth rate of the newborn infants 
during their first few weeks of life (Ehrenkranz et a!., 1999) puts significant 
pressure on the intestine to efficiently digest and absorb nutrients. This 
occurs at a time when the neonatal intestine is adapting to the enteral route 
of nutrition after a prenatal period in which amino acids were delivered via 
the umbilical route. Therefore, it may be speculated that a large quantity of 
amino acids is needed for the growth and maintenance of the premature gut 
to enable its optimal function and integrity (van der Schoor eta!., 2007). 
Mucin proteins provide the structural backbone of the mucus gels that 
provide lubrication and protection from pathogens (Allen et al., 1984; Valle, 
2012). The protein cores of these mucins contain large amounts of threonine 
(Roberton et a!., 1991) and therefore threonine is important in the 
maintenance of the mucus lining of the gut (Bertolo et a!., 1998; Lien et al., 
1997). In neonatal pigs, the portal drained viscera (PDV), metabolically 
dominated by the small intestine, accounts for only 3-6% of the total body 
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mass, but is responsible for 20-35% of the whole-body protein turnover and 
energy expenditure (Burrin et al., 2001), demonstrating its large contribution 
to the whole-body threonine metabolism. This PDV extracts 60-90% of 
dietary threonine on the first pass, whereas extraction of other essential 
amino acids is limited to about a third (Schaart eta!., 2005; Stoll eta!., 1997; 
Stoll et al., 1998b; van der Schoor et a!., 2002; Van Goudoever et a!., 2000) . 
The vast majority of this threonine is incorporated into mucosal proteins and 
only 2-9% fs oxidized (Schaart et a!., 2005) . Therefore, adequate dietary 
threonine is critical in the production of mucus and gut function (Law eta!., 
2007) . This disproportionate requirement for threonine by intestinal tissues 
has significant nutritional implications (Law et al., 2007). 
Because the overall nutrient requirement of the gut is large, it makes sense 
that the cells of the intestinal mucosa meet their nutrient requirements first 
(Baracos, 2004). However, no studies have been conducted to identify the gut 
requirement of dietary threonine. This is important to know because the 
nutrient requirements of the gut might have a critical impact on the systemic 
availability of nutrients and a substantial impact on whole-body and 
individual tissue growth and development in young animals. 
1.2 Gastrointestinal physiology and functions 
Stomach 
The stomach is a muscular sac that functions primarily as a reservoir, 
controlling the rate of delivery of food to more distal segm ents of the 
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gastrointestinal tract (GIT). The mucus layer adhered to the stomach wall 
protects the gastric mucosa against endogenous agents such as HCl and 
pepsin and dietary exogenous substances (Dekker eta/., 1991). 
Anatomically, the stomach is divided into three regions, the cardia, fundus, 
and antrum which have distinctive structures with specific functions (Barrett, 
2006). 
The cardia secretes mucus and bicarbonate to protect the surface from the 
corrosive gastric contents, while the fundus mainly functions to serve as a 
secretory region. The fundic (or gastric) glands contain specific secretory 
cells that produce gastric juice, acid from parietal cells and pepsin from chief 
cells. The antrum (pyloric zone) is involved in extensive motility patterns, 
mixing the gastric contents and grinding and sieving ingested particles. 
Finally, the food is gradually emptied into the small intestine via the pylorus 
(Barrett, 2006). 
Folds present in the stomach surface are known as rugae, which can be 
observed by the naked eye. At the microscopic level, pits further increase the 
surface area of the stomach and represent the entrances to deep gastric 
glands. The glands become deeper from the cardia, to the antrum, to the 
fundus (Barrett, 2006). 
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Small Intestine 
The small intestine (SI) is best known for its role in the digestion and 
absorption of nutrients. Its innermost layer of the wall is composed of the 
mucosa, followed by the sub mucosa, the muscle layer and the outermost 
serosa (Lin et a/., 1999). The first segment of the small intestine, the 
duodenum, begins as a bulb-shaped structure immediately distal to the 
pylorus. The remainder of the small intestine consists of the jejunum and 
ileum (Barrett, 2006). 
The majority of nutrient absorption in the healthy individual takes place in 
the jejunum. It has a markedly increased surface area to promote better 
absorption due to the presence of folds of Kerckring, tall and slender villi and 
an abundance of microvilli (Barrett, 2006), which are prominent on the 
epithelium. The epithelium, the innermost layer of mucosa facing the lumen, 
consists of columnar epithelial cells or enterocytes (Barrett, 2006; Lin eta/., 
1999). These enterocytes function in digestion, absorption, and secretion 
(Barrett, 2006; Herlinger, 1999). 
Nutrient absorption in the ileum, which has fewer folds and shorter, sparser 
villi, is low (Barrett, 2006; Lin et a/., 1999), with the exception of specific 
solutes such as conjugated bile acids. However, in impaired jejunal 
absorption, such as in mal-digestion, the ileum represents an anatomic 
reserve for absorption. 
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There are three types of smooth muscle contractions: peristaltic waves, 
segmentation contractions, and tonic contractions. Peristalsis moves the 
intestinal contents (chyme) toward the large intestine. Segmentation 
contractions move the chyme to and from the mucosal surface and increase 
exposure to it. Tonic contractions are relatively prolonged contractions and 
isolate one segment of the intestine from another (Barrett, 2006). 
Colon 
The colon, or large intestine, has a larger diameter than the small intestine 
with a thicker wall and folds known as haustrations. In the human, the large 
intestine is divided into several regions: the ascending, transverse, 
descending, and sigmoid colon (Figure 1.2). In pigs, the proximal portion of 
the descending colon is arranged in a series of centrifugal and centripetal 
coils in the left upper quadrant of the abdomen. This structure is known as 
the spiral colon. The cecum has three longitudinal muscular bands (tenia) and 
the proximal portion of the spiral colon has two bands, resulting in a series of 
sacculations (haustra). 
The colon stores wastes and indigestible materials prior to the ir e limination 
by defecation. In general, the colonic epithelial cells (colonocytes) are not 
involved in the absorption of conventional nutrients such as 
monosaccharides, peptides, amino acids, and vitamins, but other luminal 
constituents can be actively absorbed. For example, although some peptides 
and amino acids can be broken down by colonic microbes, they cannot be re-
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absorbed due to lack of amino acid transporters in the colon. However, the 
fluid remaining from digestion as well as from the other dietary by-products, 
such as short chain fatty acids produced by the bacterial fermentation of 
carbohydrates, including dietary fiber, are recycled at the ascending and 
transverse colon. Other luminal solutes, such as bile acids and bilirubin, are 
also modified in the colon by bacterial metabolism (Barrett, 2006). 
Transit time from stomach to colon 
The transit time of food from stomach into the duodenum depends on factors 
such as type of food ingested, the osmotic pressure of the material entering 
the duodenum, and gut contractions. It is fastest with foods rich in 
carbohydrate and slowest with fatty foods, whereas protein rich foods are 
moderate (Barrett eta!., 2010). Segmentation and tonic contractions reduce 
transit time in the small intestine and permit longer contact of chyme with 
enterocytes to increase nutrient absorption (Barrett, 2006). 
In humans, the first part of a test meal reaches the cecum in about 4 h in the 
small intestine, and all the undigested portions will enter the colon in 8-9 h. 
On average, the first remnants of the meal traverse the first third of 
the colon in 6 h, the second third in 9 h, and reach the sigmoid colon in 12 h. 
From the sigmoid colon to the anus, transit is much slower (Barrett et a!., 
2010). 
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1.3 Structure and physiological functions of gut mucus/mucin 
Mucus is a complex viscous adherent secretion synthesized by goblet cells in 
the columnar epithelium, which line organs that are exposed to the external 
environment, including the GIT (Bansil & Turner, 2006). The highly 
glycosylated proteins (glycoproteins) present in mucus are called "mucins" 
and consist of a large number of oligosaccharides covalently attached to a 
protein core. 
Classifications ofmucins 
The mucins are encoded by 12 different mucin genes namely; MUCl, MUC2, 
MUC3, MUC4, MUCSAC, MUCSB, MUC6, MUC7, MUCB, MUC9, MUC11 and 
MUC12 (Silva eta!., 2002). Also, mucins can be classified in three distinct 
subfamilies related to their structure: gel-forming, soluble, and membrane-
bound (Moniaux eta!., 2001). 
Based on the bound carbohydrate side chains, the mucins are further 
classified into different types. At least two different regions of peptides can be 
seen within the large glycopeptides present in the native mucin: (1) "naked" 
segments containing no carbohydrate and (2) the remaining peptide region 
contains >9 0% of the carbohydrate attached to a protein core (Wesley eta!., 
1985). 
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Composition and structure ofmucusjmucin 
Mucus is primarily composed of -95% water, but also contains glycoproteins, 
salts, and lipids such as fatty acids, phospholipids and cholesterol, as well as 
proteins with defensive functions (Allen & Snary, 1972). The protein core of 
mucus, within "mucins", have high molecular weights ranging from 0.5 to 20 
MDa (Turner eta!., 1999) and are rich in serine, threonine and proline (Table 
1.1). 
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Table 1.1: Amino acid composition of the pig small-intestinal mucus 
glycoprotein (Mantle & Allen, 1981) 
Amino acid 
Composition 
molj100mol of protein 
Lysine 2.22 
Histidine 1.37 
Arginine 2.22 
Aspartic acid 4.63 
Threonine 26.53 
Serine 10.40 
Glutamic acid 4.20 
Proline 15.44 
Glycine 5.60 
Alanine 3.77 
1/z Cystine 4.28 
Valine 7.15 
Methionine 1.25 
Isoleucine 3.14 
Leucine 4.28 
Tyrosine 1.46 
Phenylalanine 2.00 
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The linear or rod-like peptide core with oligosaccharides arranged radially 
from the central core in the basic mucin structure (Figure 1.1) provides high 
viscosity to the mucin (Lamont, 1992). The oligosaccharide chains are 
attached to the protein core by 0-glycosidic bonds to the hydroxyl side chains 
of serine and threonine and arranged in a "bottle brush" configuration about 
the protein core (Allen & Snary, 1972; Lamont, 1992). These 0-glycans are 
less branched than most N-glycans. The presence of these large numbers of 
serine and threonine residues in an uncharged and often proline-rich peptide 
context is responsible for the clustering of 0-glycans on mucins (Lamont, 
1992). This specific structure contributes to the physico-chemical properties 
of mucin such as enhancement of polymerization with very high molecular 
weight, high viscosity contributed by extended rod-like structure, protease 
resistance due to glycosylated repeating sequences, binding of toxins and 
bacteria due to availability of branched oligosaccharides, and lipid binding 
capacity by hydrophobic domains (Lamont, 1992). The carbohydrate 
constitutes> 65 % of the dry weight (Allen & Snary, 1972; Lamont, 1992) and 
variations in attached oligosaccharides (length, branching, internal linkages, 
and specific monosaccharide composition) result in the heterogeneity of 
mucins. These oligosaccharide chains may contain up to five different 
monosaccharides, namely: galactose, fucose, N-acetylglucosamine, N-
acetylgalactosamine, and sialic acid distinguished as either N-acetyl- or N-
glycollyl-neuraminic acid (Table 1.2), plus trace quantities of mannose and 
glucose (Allen & Snary, 1972; Lamont, 1992). Usually, carbohydrates are very 
hydrophilic and therefore they contribute to the gelling property of mucin 
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due to their ability to bind water. Also, they protect the peptide core from 
proteolytic attack from pancreatic and bacterial proteases, and bind 
pathogenic bacteria, parasites and toxins or sometimes mimic the natural 
binding sites for pathogens. Furthermore, oligosaccharide side chains provide 
a stable attachment site for immunoglobulins, lysozyme and digestive 
enzymes (Lamont, 1992). 
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Table 1.2: The composition of some gastrointestinal mucus glycoprotein 
(from Allen & Snary, 1972) 
Carbohydrate molar ratios 
Source 
-G u u u ~ ~ iU u ~ z z z = z u iU \.!:1 
""' = 
= G aJ aJ \.!:1 z z 
Stomach 
Human 2.4 1.0 3.1 2.1 0.2 
Pig 2.8 1.0 2.9 1.9 0.2 
Sl 
Human 1.0 1.0 2.0 0.6 0.2 
Rat 1.0 1.0 3.0 1.0 0.8 
Colon 
Human 1.0 1.0 1.1 0.5 0.7 
Pig 2.9 1.0 2.5 1.5 0.2 
Sl= Small intestine; GlcNAc = N-acetylglucosamine; 
Ga!NAc = N-acetylgalactosamine; Gal=galactose; 
Fuc=fucose; NeuNAc=N-acetylneuraminic acid; 
NeuNGI= N-glycollylneuraminic acid 
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Protein 
(%by 
weight) 
17 
13 
12 
12-16 
33 
13 
Four subunits of 500,000 kDa are linked together to form a mucin monomer 
(Figure 1.1) and two distinctly different regions can be found in mature 
mucins. The first region is the protease-sensitive amino- and carboxy-
terminals, which are very lightly glycosylated (naked region), with relatively 
few 0-glycosylation and N-glycosylation sites, and a high proportion of 
cysteine (> 10%). These cysteine residues are likely involved in establishing 
disulfide linkages within and among mucin monomers (Bell et a/., 2003; 
Lamont, 1992). This peptide core is folded like most other globular proteins 
and allows direct protein-protein interactions, which are critical for 
aggregation (Lamont, 1992). The second region is the large glycosylated 
protease-resistant central region (glycosylated region), formed of multiple 
tandem repeats that are rich in serine, threonine and proline (STP repeats) 
with> 60% of the amino acids. This area becomes saturated with hundreds of 
0-linked oligosaccharides. N-linked oligosaccharides are also found on 
mucins, but much less abundantly (Bell eta/., 2003; Lamont, 1992). 
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Monomer 
(MW 2,000,000) 
Subunit 
Peptide Core 
Naked Region 
(protease-sensitive) 
Glycosylated Region 
(protease-resistant) 
Figure 1.1: Schematic representation of a typical intestinal mucin 
(adapted from Lamont, 1992) 
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Functions and biological significance of gut mucusjmucin 
The highly viscous mucus gel covering the GIT lubricates the passage of 
food/chyme and a lso acts as a permeable gel layer for the exchange of gases 
and nutrients w ith the underlying epithelium (Bansil & Turner, 2006). The 
mucosal defense system, which is composed of pre-epithelial, epithelial, and 
sub-epithelial elements, provides a three-level barrier. The mucus-
bicarbonate-phospholipid layer provides a first line of defense by serving as a 
physico-chemical barrier to multiple molecules, toxins and pathogens (Allen 
et a/. , 1984; Valle, 2012) by protecting underlying mucosal surfaces from 
abrasion, acid, digestive enzymes and bacterial invasion (Allen eta/., 1984). 
Both the non-stirred water layer and bicarbonate are secreted in a regulated 
fashion by the gastric-duodenal surface epithelial cells of the mucosa. The 
water layer of the mucus gel obstructs ion diffusion, including hydrogen ions 
and molecules such as pepsin, while bicarbonate is secreted into the mucus 
gel, thus forming a pH gradient of 1-2 at the gastric luminal surface which 
reaches 6-7 along the epithelial cell surface (Valle, 2012). Additionally, mucus 
contains lysozyme, immunoglobulins, defensins, growth factors and trefoil 
factors to defend against pathogens (Bansil & Turner, 2006). The great 
diversity in mucin 0-glycan structures provides optimal protection against a 
variety of pathogenic agents and microbes in the intestines (Brockhausen, 
2004). Further, intestinal mucosa represents a suitable place for beneficial 
gut microbiota. For example, bacteria are known to adhere specifically to 
partial oligosaccharide sequences found in mucins, and multiple attachment 
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sites for these commensal bacteria colonizing the gut may prevent binding 
for a few pathogenic ones (Brockhausen, 2004). 
In human intestinal mucin, the composition of naked segments, which are 
sensitive to attack by proteases, is constant (Wesley et a!., 1985) and these 
segments provide a major antigenic effect (Mantle et a!., 1984). 
Oligosaccharides present in the remaining peptide region play a main role in 
maintaining the structure and conformation of mucins (Veluraja eta!., 2011), 
and provide considerable water-holding capacity and also make them 
resistant to proteolysis by digestive enzymes. The high molecular weight 
mucins are responsible for the viscoelastic properties of the mucus barrier 
(Gendler & Spicer, 1995) and mucins promote gelation by cross-linking in a 
solution by disulfide bonding (Marth, 1999). However, the glycoprotein 
constituents and thickness of the gel differ from region to region within the 
gut (Allen eta!., 1984). 
1.4 Threonine and its requirements 
Proteins are vital to health because they support the growth and repair of 
structural and functional components of the body. Amino acids serve as the 
building blocks for these proteins and their requirements can be affected by 
many factors, including age, body weight, sex, genotype, environment 
(climate, microbial, social), and dietary factors (De fa eta!., 1999). With these 
multiple factors, it is rather difficult and impractical to condu ct experiments 
to determine the amino acid requirements for each individual group and 
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situation. Therefore, estimates of amino acid requirements have large 
variations. 
Threonine is an indispensable amino acid for poultry (Kidd & Kerr, 1996), 
pigs and humans (Defa et a/., 1999; Le Floc'h et a/., 1996), and its oxidation 
represents an irreversible loss for body protein because it cannot be 
synthesized de novo by mono-gastric animals (Le Floc'h et a/., 1996). 
Moreover, threonine is the second limiting amino acid in common cereals 
used in swine diets including, sorghum (Cohen & Tanksley, 1976), barley 
(Fuller eta/., 1979) and wheat (Allee & Hines, 1971), and the third limiting 
amino acid in corn (Grosbach eta/., 1985). 
In pigs, threonine has been identified as the first limiting amino acid for 
maintenance (Fuller eta/., 1989) and its utilization for processes other than 
muscle protein synthesis and deposition is high (Le Floc'h & Seve, 2005). 
Growing animals have a higher threonine requirement and their total 
requirement must depend on the relative contributions of maintenance and 
tissue protein accretion to its total needs (Fuller et a/., 1989). Therefore, an 
adequate supply of dietary threonine is important to maintain protein 
synthesis and deposition (Le Floc'h eta/., 1996). 
Threonine is also critical for the production of gut mucins and also 
contributes to collagen, elastin, and tooth enamel formation 
(VIaardingerbroek et a/., 2011). As threonine has quantitatively important 
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functions in the gut, the threonine requirement is different according to the 
mode of dietary intake. For example, the threonine requirement for piglets 
-8 days of age was 0.20 g.kg·1.day-1 when fed intravenously and 0.55 g.kg· 
1
.day·1 when fed intragastrically (Bertolo eta!., 1998), indicating a three times 
higher requirement when the gut is healthy and intact. 
Imbalances of threonine intake (both deficiency and excess) can cause 
detrimental effects, especially during the neonatal period. Wang eta!. (20 07) 
found that protein synthesis rate was r educed in the small intestine of piglets 
receiving either 50% or more than 100% of daily threonine 
recommendations. A high threonine intake increases serum and brain 
threonine concentration (Kang-Lee & Harper, 1978) and leads to a decrease 
of food intake and growth failure (Muramatsu eta!., 1971) in animals. On the 
other hand, feeding young piglets a threonine deficient diet (70 % of 
recommendations) for 2 weeks induced villous atrophy in the ileum (Hamard 
eta!., 2007) and a 40% reduction in dietary threonine in rats led to reduced 
fractional synthesis rate of intestinal mucins without any effect on total 
mucosal protein synthesis rate (Faure eta!. , 2005). Recently, Hamard eta/. 
(2010) demonstrated that a 30% reduced threonine supply for 2 weeks 
induced paracellular permeability and reduced glucose absorption capacity in 
weaning piglets. A similar threonine deficient diet also resulted in reduced 
total threonine contents of carcass, colon and liver by 4%, 7% and 11%, 
respectively. These authors assumed that the reduction in threonine content 
could be associated with a deposition of proteins less rich in threonine. For 
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example, the reduction in threonine content in the colon, also described in 
other studies (Law et al., 2007; Wang et al., 2007), could be ascribed to a 
reduction in mucin synthesis and content. 
A deficiency in a particular amino acid induced by an excess of one or more 
dietary amino acids can also cause amino acid imbalance. For example, a 
threonine deficiency can be caused by a slight excess of methionine in rats 
(Salmon, 1958). As dietary methionine increased, the growth rate decreased 
and additional dietary threonine alleviated the decrease in growth. Castagne 
et al. (1993) showed that a high dietary content of threonine (5.8g/100g diet, 
i.e. 15 times the normal levels) can change the amino acid balance by 
elevating glycine levels in the brain. However, diets containing only 2 to 4 
times the normal levels of threonine are insufficient to modify brain glycine, 
in spite of inducing a weak hyperthreoninemia. The brain neurotransmitters, 
catecholamines, serotonin, and histamine, are dependent on the supply of 
their precursor amino acids, phenylalanine/tyrosine, tryptophan, and 
histidine, respectively. High plasma threonine concentration due to high 
dietary threonine intake can reduce the entry into the brain of the other 
neutral amino acids through competition at the level of transport systems at 
the blood-brain-barrier, thereby disturbing the levels of those 
neurotransmitters in the brain. If the plasma threonine concentration is 
sufficient to compete and depress the brain supply of indispensable amino 
acids, then protein synthesis might also be impaired (Castagne et al., 1993; 
Wu, 1998). Yoshida et al. (1966) found that dietary amino acid imbalance in 
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rats caused by the addition of an amino acid mixture with limited threonine 
or histidine causes a decrease in plasma levels of these indispensable amino 
acids due to more efficient incorporation of them into tissues. It has also been 
suggested (Kidd & Kerr, 1996) that there is a homeostatic mechanism in rats 
which holds body lysine levels constant while body threonine fluctuates 
depending upon the amount present in the diet. The lack of such a 
homeostatic mechanism regulating threonine may result in a more variable 
requirement estimate. When dietary lysine levels are lower than the 
requirement, all absorbed lysine which is not used for maintenance or not 
oxidized will go to skeletal muscle accretion (Kidd & Kerr, 1996). 
1.5 Threonine utilization in the gut 
As an indispensable amino acid in mammals, functions involving threonine 
are dependent on an adequate supply of dietary threonine. Dietary threonine 
is absorbed in the small intestine and then used by the peripheral tissues 
mainly for protein deposition associated with growth and maintenance 
(Hamard eta!., 2009) . During this intestinal absorption, more than one half of 
orally supplied threonine is extracted on first-pass by the small intestine of 
young pigs (Le Floc'h & Seve, 2005; Stoll eta!., 1998b; van der Schoor eta!., 
2002). Further, many studies (Schaart eta!., 2005; Stoll eta/., 1998b; van der 
Schoor et al., 2002; Van Goudoever et al., 2000) have demonstrated that the 
portal-drained viscera (PDV; the intestine, pancreas, spleen, and stomach), 
metabolically dominated by the small intestine, extracts 60- 90% of dietary 
threonine on the first pass (Stoll et al., 1998b), whereas extraction of other 
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essential amino acids is limited to about a third. In preterm infants, the 
splanchnic tissues retain dietary threonine to a similar degree ( -7 5%), 
regardless of the amount of enteral threonine delivery (van der Schoor eta!., 
2007). This high obligatory requirement for threonine by the portal-drained 
viscera may be due to its abundance in mucosal proteins (Schaart et al., 
2005). Interestingly, additional data demonstrated a substantial portion of 
the oral threonine intake by piglets is used by the healthy gut and is not 
required when the gut is relatively inactive or atrophied, as during parenteral 
feeding (Bertolo et al., 1998). The colon and the carcass utilize amino acids 
from blood whereas the small intestine uses mostly luminal amino acids for 
protein synthesis (Schaart et al., 2005; Le Floc'h & Seve, 2005), which helps 
explain the disproportionate requirement and utilization of dietary threonine 
by small intestinal tissues. Furthermore, this high threonine extraction by the 
small intestine on first-pass is nutritionally important, because it determines 
threonine availability for non-digestive tissues that depend on threonine 
supplied by the blood. 
A threonine deficient diet results in GIT-related consequences such as 
diarrhea, reduced intestinal protein synthesis (Wang eta!., 2007), ileal villous 
hypotrophy (Hamard et al., 2007), and reduced mucin synthesis and content 
(Faure eta!., 2005; Law eta!., 2007; Wang eta!., 2007). Mucin has a threonine 
content of 13-26% of total AA (Lien et al., 1997; Mantle & Allen, 1981; Pie! et 
al., 2004). Therefore, the dietary, rather than systemic, threonine is 
preferentially utilized for protein (Cid et al., 1999; Schaart et al., 2005) and 
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mucin (Faure eta/., 2005; Law eta/., 2007; Wang eta/., 2007) synthesis in the 
small intestinal mucosa. Hence, the reduced protein synthesis due to a 
threonine deficient diet may specifically reflect reduced mucin synthesis. 
However, it should be noted that others have not observed similar results. 
For example, Hamard eta/. (2007) found that a low dietary threonine supply 
(6.5 g/100 g diet) to piglets did not alter intestine growth and architecture of 
the proximal small and large intestine. Additionally, a marginally threonine 
deficient diet did not affect protein metabolism of the small intestine, 
whereas modifications in protein threonine content in th e carcass, the liver 
and the colon of piglets were observed (Hamard et a/., 2009). On the other 
hand, both di etary threonine restriction and excess have been shown to 
reduce fractional synthesis rate of small intestinal mucosal protein and 
mucins (Van Goudoever eta/., 2000; Wang eta/., 2007) but had no effect on 
total mucosal protein synthesis (Faure eta/., 2005). A possible explanation 
for the same outcome due to excess of threonine may be a reduction in the 
uptake of neutral amino acids by the intestinal mucosa due to their sharing 
the same transport systems, thereby limiting the local synthesis of proteins 
(Castagne eta/., 1993; Wu, 1998). The uptake of amino acids across the small 
intestinal epithelium occurs in two stages, 1) uptake across the brush-border 
membrane, and 2) exit into the blood across the basolateral membrane. 
Transport across the basolateral membrane occurs via the classical transport 
systems, namely the Na-independent system L and the Na-dependent systems 
A and ASC (Mircheff et a/., 1980). Simple diffusion of amino acids across a 
membrane also contributes to their net movement. The basolateral 
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membrane of the enterocyte is much more permeable to amino acids than in 
non-epithelial membranes or the brush-border membrane (Stevens et a!., 
1984). The leaky nature of this membrane allows accumulated amino acids to 
diffuse from the enterocyte to the blood. However, when gut luminal amino 
acid concentrations are low, the carrier-mediated pathways are important for 
amino acid uptake into the enterocyte. Amino acid transport across the 
brush-border membrane also can be Na-independent and Na-dependent 
processes. Large neutral amino acids and cationic amino acids in the small 
intestine share Na-dependent and Na-independent transport systems 
(Harvey eta!., 1993; Munck & Schultz, 1969; Wolfram eta!., 1984) and brush-
border membrane vesicles from fetal and adult small intestine also 
demonstrate the presence of Na-dependent and Na-independent transport 
systems for neutral amino acids (Lucke eta!., 1977). Threonine transport is 
usually depressed more by large neutrals, rather than small neutrals (Tovar 
eta!., 1988). 
Therefore, in young pigs, the small intestine may be very sensitive to dietary 
threonine levels with regard to tissue protein synthesis. 
1.6 Intestinal threonine metabolism 
Amino acids can be utilized for 3 main metabolic purposes after absorption: 
1) protein synthesis, 2) conversion to other amino acids, metabolic substrates 
and biosynthetic intermediates, and 3) complete oxidation to COz. 
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The gastrointestinal tissues have an important impact on the whole-body 
metabolism of animals due to their relatively high protein turnover rate and 
high oxygen consumption (Burrin eta!., 2001). Although the small intestine 
represents Jess than 5% of whole body mass, it accounts for 20-50% of total 
body protein turnover and energy expenditure in pigs. Further, the fractional 
rate of protein turnover in intestinal tissues exceeds that of peripheral tissues 
(Burrin et al., 2001). This high metabolic activity partially explains the high 
amino acid requirements of the gut. The small intestine can use amino acids 
from either the lumen or artery and the contribution of these two sources can 
be changed according to the nutritional status of the animal and the amino 
acids (Stoll et al., 1997) However, in normal conditions, the small intestine 
uses mostly luminal amino acids for protein synthesis (Le Floc'h & Seve, 
2005;Schaarteta~,2005). 
Since threonine is the first limiting amino acid for maintenance in pigs (Fuller 
eta!., 1989), most of the maintenance requirement could be attributed to the 
incorporation of threonine in digestive tract protein synthesis (Le Floc'h & 
Seve, 2005). Because there is no significant threonine recycling from mucosal 
proteins (van der Schoor et al., 2002), it seems that these mucosal proteins 
are very resistant to digestion. Alternatively, recycled threonine might be 
immediately reincorporated into mucosa protein instead of being absorbed 
or lost in the lumen (Le Floc'h & Seve, 2005; van der Schoor et al., 2007). In 
either event, it appears that the threonine that is extracted by the gut is 
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irreversibly metabolized, either by being incorporated into digestion-
resistant mucin proteins, or by catabolism. 
Three enzymes participate in threonine catabolism, namely, threonine 
dehydratase (TDH), threonine dehydrogenase (TOG), and threonine aldolase 
(Figure 1.2). In pigs, more than 80% of threonine catabolism occurs through 
the TOG pathway to produce glycine and acetyl CoA in vivo (Le Floc'h et a!., 
1996). However, in adult humans, only 7-11 % of threonine catabolism occurs 
via TOG pathway (Darling eta!., 2000) and over 80% is via TDH. TDH (also 
known as serine dehydratase) uses pyridoxal-5'-phosphate to degrade 
threonine to 2-ketobutyric acid and ammonia, and this reaction becomes 
important only during fasting in pigs (Kidd & Kerr, 1996) and the 
contribution of TDH to whole body threonine catabolism during the fed state 
is probably less than 20% (Ballevre et a!., 1990; Ballevre et a!., 1991). 
Threonine degradation to glycine and acetaldehyde by threonine a ldolase is 
considered very minor in both pigs and humans (Kidd & Kerr, 1996). In vivo, 
threonine catabolism depends on the amount of active enzyme and the 
availability of threonine as substrate. Plasma threonine concentration, as well 
as threonine transport into the tissue, is the major factor controlling the flux 
of threonine catabolism through the TOG pathway (Le Floc'h & Seve, 2005). 
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Figure 1.2: Schematic representation of threonine catabolism (Used with 
permission of The Journal of Applied Poultry Research; Kidd & Kerr, 1996, 
vo! S) 
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If threonine degradation occurs in the gut, an increase in intestinal threonine 
catabolism associated with an increase in dietary threonine could partially 
explain the gut's high requirement for threonine. However, similar to most of 
the essential amino acids, threonine catabolism in pigs occurs mainly in the 
liver, but also in the pancreas (Le Floc'h et a/., 1997); no TOG enzymatic 
activity to degrade threonine has been detected in the small intestine, colon 
and associated lymphatic nodes in pigs (Le Floc'h & Seve, 2005; Le Floc'h et 
a/., 1997; Wu, 1998) . Hence, the precursor pool for threonine oxidation is 
likely represented by intrahepatic threonine. Nevertheless, when dietary 
threonine supply is limiting, the main part of threonine oxidation could be 
extrahepatic (Le Floc'h & Seve, 2005). Although the highest specific activity of 
TOG occurs in the pancreas, the activities of TDH and threonine aldolase are 
highest in liver and muscle in pigs (Davis & Austic, 1994a in Kidd & Kerr, 
1996). This lack of detectable enzyme activity in the intestine (Wu, 1998) 
could be the consequence of the high protease activity in the intestinal 
mucosa (Le Floc'h & Seve, 2005), complicating its measurement. However, 
other methods have demonstrated that most of the dietary threonine 
extracted by the small intestine is incorporated into mucosal proteins 
synthesis and only 2-9% is oxidized (Schaart et a/., 2005) . It has also been 
found that the plasma threonine concentration is directly proportional to the 
dietary true ileal digestible threonine (TIDT) level (Yamashita & Ashida, 
1971). Glycine is a product of threonine catabolism in mammals, including 
pigs (Le Floc'h eta/., 1995), and therefore, increasing dietary levels of TIDT 
from 0.37 to 0.74% increased plasma concentrations of glycine. However, a 
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further increase in dietary threonine level beyond 0.74% TIDT does not cause 
further increase in plasma glycine concentration, suggesting a limited 
threonine catabolism capacity through hepatic TOG pathway (Wang et a/., 
2007). It is unknown whether intestinal threonine catabolism is upregulated 
at such high dietary threonine intakes to enhance the overall whole body 
threonine oxidation capacity. 
1. 7 Swine as an animal model for metabolic studies 
The pig is an increasingly important animal model in many aspects of 
biomedical research, including embryology, teratology, nutrition, metabolism 
and immunology (Book & Bustad, 1974; Miller & Ullrey, 1987; Nunoya eta/., 
2007). There are over SO breeds of miniature pigs (minipigs) that can be 
found worldwide, but only a few of them are important in biomedical 
research (Michael & Smith, 2008) including Yucatan, Hanford, Sinclair and 
Gottingen (Murtaugh eta/., 1996; Nunoya eta/., 2007). These minipigs have 
been established from naturally occurring populations and from the genetic 
selection of two or more existing breeds. Yucatan minipigs, who are 
essentially hairless and have a docile temperament, were developed at 
Colorado State University from found ation animals imported from the 
Yucatan peninsula in 1960 (Nunoya et a/., 2007). They have a mean birth 
weight of 0.74 kg and mean weaning weight at 60 days of 6.47 kg (Nunoya et 
a/., 2007). 
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Piglets are the best animal models for research involving the physiology of 
digestion and metabolism compared with most of the other commonly used 
research animals such as rodents, dog, cat, goat and sheep. The piglet is very 
similar to a newborn human infant, especially with respect to anatomical, 
physiological, gastrointestinal, respiratory, renal, cardiovascular and 
hematologic systems (Book & Bustad, 1974; Miller & Ullrey, 1987; Nunoya et 
a!., 2007). Therefore, nutrient requirements of the pig resemble the human in 
more ways than any other non-primate mammalian species allowing the use 
of the pig in human nutritional studies including calorie-protein malnutrition, 
and nutrient absorption and metabolism (Miller & Ullrey, 1987). However, 
there are some significant anatomical differences in the large intestine 
(Michael & Smith, 2008), including a large cecum and a spiral colon. 
Minipigs have special advantages: easily handled because of its inherently 
smaller size even at full maturity, easily housed, economical, easily treated, 
and they also have few health problems (Book & Bustad, 1974; Michael & 
Smith, 2008; Miller & Ullrey, 1987; Nunoya eta!., 2007). Other advantages 
include rapid growth rate (Miller & Ullrey, 1987; Nunoya et a!., 2007), 
controlled genotype (Nunoya et a!., 2007), large litter size and the two to 
three litters per sow per year (Book & Bustad, 1974; Nunoya eta!., 2007). 
Also, they enable collection of larger volumes of multiple samples of body 
fluids or biopsies compared to rodents (Nunoya eta!., 2007) . Moreover, they 
are more tractable than the domestic breeds raised in an agricultural setting 
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allowing successful performance of experiments under unstressed conditions 
(Nunoya eta!., 2007). 
Compared to a human infant, the piglet has a lower birth weight, higher 
metabolic rate, higher body temperature and smaller fat reserve (Miller & 
Ullrey, 1987). However, there are some similarities in the portions of total life 
to reach chemical maturity and the chemical compositions of fat-free body 
tissue at common stages of life for humans and pigs (Table 1.3). However, the 
piglet grows very rapidly and therefore has more strict nutritional 
requirements than a human infant. In the first 6 weeks of life, the domestic 
piglet increases its birth weight by 1000% (from 1,200 to 12,000 g) 
compared to the human infant which increases its birth weight by about 50% 
(from 3400 to 5000 g; Miller & Ullrey, 1987). 
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Table 1.3: Age and chemical development comparison of man and pig 
(Miller & Ullrey, 1987 in Moulton, 1923). 
Human Pig 
Length of gestation (days) 285 114 
Approximate length of life (years) 80 20 
270-
Age at chemical maturity (days) 1285 
420 
Portion of total life to reach chemical maturity (%) 4.4 4.6 
Composition at birth (fat-free basis) 
• Water(%) 82 82 
• Protein (%) 14 13 
• Ash(%) 3 3 
Composition at 3 months (fat-free basis) 
• Water(%) 81 77 
• Protein (%) 16 19 
• Ash(%) 3 4 
Composition at maturity (fat-free basis) (33 y) (3 y) 
• Water(%) 69 72 
• Protein (%) 21 23 
• Ash(%) 9 4 
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Chapter 2: EXPERIMENTAL RATIONALE, HYPOTHESIS AND 
OBJECTIVES 
2.1 Principle of tissue-specific requirement breakpoint analysis 
In the flooding dose technique, a large dose of phenylalanine is injected with 
a tracer dose of phenylalanine. This fixed phenylalanine specific radioactivity 
rapidly equilibrates w ith all free phenylalanine pools in the body. The 
isotopic steady state from the dose is maintained and then the incorporation 
of label into protein is measured. From these data, the rate of protein 
synthesis of individual tissues can be calculated. 
When threonine is deficient, protein synthesis will be reduced even when all 
other essential amino acids are available. As threonine intake increases, rate 
of protein synthesis also will be increased. When the maximal fractional rate 
of protein synthesis is reached, the plot of rate of protein synthesis against 
threonine intake will follow a plateau (Figure 2.1). This inflection point is the 
"breakpoint" and the threonine intake at this breakpoint is the "threonine 
requirement" of that particular tissue. Similarly, different breakpoints or 
threonine requirements can be identified for each individual tissue. 
Biologically, protein dynamics are not linear when amino acids are limiting. 
However, beyond the amino acid requirement, protein dynamics should be a 
plateau. Therefore, even if this relationship is curvilinear, breakpoints can be 
identified using two linear regressions. 
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Figure 2.1: Theoretical plot of protein synthesis over increasing threonine 
intakes showing the 'breakpoint' 
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Flooding dose technique: 
A very large dose of unlabelled amino acid along with a tracer sufficient to 
flood all possible precursor pools will be given intravenously. This flood 
ensures that all tissues have nearly the same specific radioactivity, which is 
then maintained almost constant during the period of incorporation into 
protein (Garlick et a/., 1980). For example, when a large dose of unlabelled 
phenylalanine is given with labelled phenylalanine, then the specific 
radioactivity of phenylalanine in liver and small intestine rise rapidly to a 
value close to that in plasma and then fall slowly, but linearly. This allows the 
average specific radioactivity of free phenylalanine during a short period of 
labelling to be estimated from a tissue. The main advantage of this technique 
is its ab ility to measure the rate of protein synthesis in tissues with very 
rapid protein turnover, such as liver and gut (McNurlan eta/., 1979) due to 
its ability reach isotopic steady state rapidly. This short duration also allows 
more accurate definition of the metabolic state of the animal (Garl ick et a/., 
1973). Use of phenylalanine is preferable as it is an essential biochemical 
requirement in mammals, it has higher solubility which allows giving a larger 
dose, the pool of free phenylalanine in tissues is smaller, it has a reasonably 
uncomplicated and non-reversible metabolism, it has a comparatively low 
expense, and it has more convenient, rapid, sensitive and reliable analytical 
quantification methods (Garlick et a/., 1980; Schaefer & Scott, 1993). Also, 
perhaps most importantly, a large dose of phenylalanine injected does not in 
itself influence rates of protein synthesis in tissues (Garlick et a/. , 1980). 
However, use of this technique for large animals r equires a large volume of 
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unlabeled amino acid that has to be given over minutes or hours with 
sufficient label, which needs more sensitive analytical techniques and also 
increases the cost of the experiment (Schaefer & Scott, 1993). 
2.2 Rationale 
When dietary threonine is limiting, intestinal tissues will sequester a greater 
proportion of threonine to meet their needs, especially for mucin production, 
at the expense of extra-intestinal tissues. As threonine intake increases above 
the gut requirement, other tissues will increase protein synthesis until their 
needs are met. By comparing these tissue-specific breakpoint requirements, 
w e can determine which tissues are prioritized or spared when threonine is 
limiting. 
2.3 Hypothesis 
Mucin-producing tissues, especially gut, sequester limited dietary threonine 
for protein synthesis at the expense of other tissues. 
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2.4 Objectives 
1. To determine the threonine requirement of different tissues for protein 
synthesis. 
2. To identify whether mucin-producing tissues sequester dietary 
threonine for protein and/or mucin synthesis compared with other 
tissues when dietary threonine is limiting. 
3. To identify the effect of dietary threonine intake on threonine 
dehydrogenase activity in the liver. 
4. To determine the rate of mucin synthesis in mucin-producing tissues 
with varying levels of dietary threonine intake. 
5. To determine the total body threonine requirement using plasma 
threonine response curve. 
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Chapter 3 :METHODOLOGY 
3.1 Animals and surgery 
The Animal Care Committee of Memorial University of Newfoundland 
approved the animal utilization protocol for this study. 
Twenty Yucatan suckling miniature piglets (age: 15±1 d; weight: 3.1±0.3 kg) 
were r emoved from the sows at the Vivarium Pig Breeding Station of 
Memorial University and delivered to Biotechnology building for surgery. 
Upon arrival, piglets were weighed and pre-anaesthetized with an 
intramuscular injection of acepromazine (0.5 mgjkg) plus ketamine (22 
mgjkg). The piglet was given an IM injection of atropine (0.05 mgjkg) to 
reduce airway secretions and had an endotracheal tube put in place to 
maintain the airway. The piglet then r eceived gas anaesthesia consisting of 
isoflurane (1-2 %) delivered with oxygen (1.5 L/min), was restrained in the 
supine position, and kept warm with a heating pad placed under a sterile 
surgical towel. Animals were fitted with 2 venous catheters, one for blood 
sampling (femoral vein a dvanced to inferior vena cava) and one for 
intravenous infusions (jugular vein advanced to superior vena cava). They 
were also fitted with a gastric catheter using a Stamm gastrostomy for 
intragastric feeding of the experimental diets. Each venous catheter w as 
flush ed with heparinized saline (20 U/mL) to avoid any possible blockages 
due to blood clots. 
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3.2 Post-surgery care 
Immediately following surgery, piglets were given an intramuscular injection 
of Temgesic (0.03 mgjkg of buprenorphine hydrochloride). This analgesic 
was repeated twice daily until Day 3 of the post-op, as required. Immediately 
following surgery, piglets were also given an intravenous injection of 0.5 mL 
of the antibiotic mixture Borgal (40 mg/mL trimethoprim and 200 mg/mL 
sulfadoxine). Thereafter, 0.5 mL of the same antibiotic mixture Borgal was 
diluted to 10 mL with non-heparinized saline and administered through both 
femoral and jugular catheters (half into femoral and half into jugular) daily 
until Day 5. 
3.3 Animal housing 
The piglets were housed in circular metabolic cages (0.5 m height, 1 m 
diameter) that allow visual and aural contact with each other. Each cage was 
fitted with heat lamps for additional heat. Each piglet was fitted with an 
adjustable clean cotton jacket with an anchoring button attached to a tether 
so that piglets have free movement inside the cage without tangling catheters. 
Toys were provided to each piglet for stimulation. 
3.4 Diets 
Piglets received a continuous infusion through the tether-swivel system of a 
complete, elemental sterile diet that provided all nutrients required (Bertolo 
eta!., 1998). The diet's amino acid profile was based on human milk protein 
and met 120% of each amino acid's requirement fo r neonatal piglets 
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(NRCSoS, 1998); for threonine, the requirement determined by Bertolo eta!. 
(1998) was used (i.e., 100% = 0.42 g threonine/kg/d; Table 3.1). This di et 
was infused intravenously immediately post-surgery (Day 0) at a volume that 
provided SO% of the piglets ' full infusion rate. On the morning of Day 1, the 
diet was infused intragastrically at SO%; the rate was increased to 7S% in the 
middle of the day; and that evening, diet infusion was increased to full rate 
(13.5 mL/kg/h). Each morning, piglets were weighed and the rate of diet 
infusion was adjusted according to the daily weight. The blood sampling 
catheter was flushed daily with heparinized saline and blood samples (S mL) 
were collected once daily until Day 4. Plasma was separated and stored at -
80°( for later analysis. 
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Table 3.1: Amino acid composition of the complete diet 
Amino acid (AA) g AA/kg body weight/d 
Alanine 1.66 
Arginine 0.94 
Aspartic acid 0.94 
Cysteine 0.22 
Glutamic acid 1.63 
Glycine 0.48 
Histidine 0.48 
Isoleucine 0.72 
Leucine 1.62 
Lysine-HCI 1.61 
Methionine 0.30 
Phenylalanine 0.82 
Proline 1.29 
Serine 0.87 
Taurine 0.08 
Threonine 0.50 
Tryptophan 0.33 
Tyrosine 0.12 
Valine 0.82 
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The complete diet was fed until the evening of Day 4 when test diets were 
begun. Each pig randomly received one of 20 test diets, each containing a 
different threonine concentration (ranging between 0.54-5.99 g/100 g AA or 
20%- 220% of requirement: 100% = 0.42 g threonine/kg/d as identified in 
Bertolo eta!. (1998)). All diets were made isonitrogenously by manipulating 
alanine content. Composition of all other amino acids and nutrients were the 
same as the complete diet. 
3.5 Flooding dose infusion 
Nearly 24 hours after starting the experimental diet, a flooding dose of 1 
mCi/kg body weight of labeled L-[3 H]phenylalanine mixed with unlabeled 
phenylalanine (150 mmol/L, 10 mL/kg body weight) was infused 
intravenously over 5 min (Brunton eta/., 2012). Blood (1.5 mL) was sampled 
in heparinized saline tubes at 30 min after the initiation of isotope infusion; 
plasma was separated by centrifugation at 4°C and stored at -80°C for late r 
analysis. 
3.6 Sample collection and processing 
Immediately following the last blood sample, piglets were anaesthetized with 
halothane/oxygen by mask and a mid line incision was made to expose the 
intestine. Sixty centimeters of intestine was removed at 15 em and 300 em 
distal to the ligament of Treitz and labeled as proximal jejunum and mid 
jejunum, respectively. Another 60 em segment of small intestine was 
removed at thirty centimeters from the ileo-cecal valve and labeled as the 
41 
ileum. The intestinal sections of gut were flushed with ice cold sterile 0.9% 
saline and cut lengthwise to expose the lumen. On a glass plate on ice, 
mucosa was collected by firmly scraping along the gut section recovering the 
entire mucosal tissue leaving only muscularis. All tissues and mucosa were 
weighed, snap frozen in liquid nitrogen and stored at -BOaC for later analysis. 
The distal one third of the stomach (pylorus), distal colon, gastrocnemius 
muscle, longissimus dorsi muscle, right kidney, left liver lobe and right lung 
were also rapidly removed, weighed, snap frozen and stored at -80°C for later 
analysis. The piglets were killed under anaesthesia via exsanguination after 
removal of tissues. 
3. 7 Rate of tissue protein synthesis 
The methods for the measurement of tissue free and bound amino acids were 
adapted from those of Garlick eta/. (1980) with some modifications. 
Tissu e [ree amino acid quantification 
Tissue free amino acids were extracted by homogenizing 1 g of tissue in 3 mL 
of cold 2% perchloric acid (PCA) and centrifuged at 4000xg for 15 min. 
Supernatant was separated and the pellet was homogenized two more times 
making the total volume of the supernatant 9 mL. The pellet of precipitated 
protein was stored at -20°C for tissue bound amino acid determination. Fifty 
11L of 0.5 11Ci 3H-Ieucine and 100 11L of 25 mM norleucine were added to the 
supernatant as internal standards and stored at -20°C for further analysis. 
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Acid present in the 3 mL of supernatant was neutralized with 375 11L of 2 M 
KzC03 and centrifuged at 4500xg for 3 min. One milliliter of the supernatant 
was freeze-dried overnight and stored at -20°C until derivatization. 
Tissue bound amino acid quantification 
Protein pellets were re-dissolved with 8 mL of 1 M NaOH solution and 
solubilized in 37°C water bath for 1-3 hours until clear. Fifty 11L of the 
suspension was stored at -20°C for total protein analysis using the Biuret 
method. Protein was recovered by adding 4 mL of ice cold 20% PCA and kept 
in an ice bath for 20 min. Precipitated protein was centrifuged at 3000xg for 
15 min and the supernatant was discarded. Two hundred 11L of 0.5 11Ci 3H-
leucine and 400 11L of 25 mM norleucine were added as internal standards to 
the tube with the pellet and hydrolyzed with 10 mL of 6 M HCl for 24±0.5 
hours at 110°C. After allowing hydrolysates to cool overnight in the 
fumehood, the hydrolyzed sample was diluted up to 25 mL with HPLC-grade 
water and filtered using a filter paper (size 54). One mL was dried down 
overnight under vacuum oven to evaporate the HCl and was subsequently 
derivatized. 
Plasma amino acid composition 
One hundred 11L of the last plasma sample (taken just before the flooding 
dose infusion) was mixed with 20 11L of 2.5 mM norleucine. Protein was 
precipitated in 1 mL of 0.5% trifluoroacetic acid (TFA) in methanol and 
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centrifuged at SOOOxg for S min. Separated supernatant was freeze-dried 
overnight and derivatized. 
Amino acid concentration in plasma was calculated as: (AUC amino acid I 
AUC norleucine) x (11mol norleucine added I volume of plasma). 
Phenvlisothiocvanate {PITC] derivatization and amino acid identification 
Samples were first made basic by adding 100 11L (for tissue bound and tissue 
free amino acid samples) or SO 11L (for plasma samples) of freshly prepared 
triethylamine (TEA) : methanol :water solution in a 1:1:3 volume ratio and 
freeze-dried for 1 hour to form deprotonated amines, which are more 
reactive to PITC. Samples were then derivatized by adding SO 11L (for tissue 
bound and tissue free amino acid samples) or 20 11L (for plasma samples) of 
freshly prepared derivatizing solution (water : TEA : methanol: PITC in 
1:1:7:1 ratio). After a 3S min reaction, samples were frozen in liquid nitrogen 
and freeze-dried overnight. Derivatized samples were re-suspended in 300 
11L (for tissue bound and tissue free amino acid samples) or 200 11L (for 
plasma samples) of sample diluent (710 mg of NazHP04 in 1 L was titrated to 
pH 7.4 with 10% H3P04 and mixed with 5% of total volume with 
acetonitrile). Supernatants were separated by centrifuging at SOOOxg fo r 5 
min and re-centrifuged again if necessary. 
Samples were inj ected (30 11L for tissue bound amino acid analysis, 10 ~-tL for 
tissue free amino acid analysis and 4 0 IlL for plasma amino acid analysis) and 
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amino acids were separated by reverse-phase HPLC on a C18 column 
(Waters). Fractions (3 min) corresponding to tyrosine, leucine and 
phenylalanine peaks were collected from tissue bound and tissue free amino 
acid samples. The radioactivity associated with each amino acid was 
measured as disintegrations per m inute (dpm) using a liquid scintillation 
counter with added scintillant (10 mL of Scintiverse in 3 mL fractions). 
Counting error was kept below 5%. 
Calculations 
Th e rate of tissue protein synthesis (Ks) w as calculated using the equations 
below as in Garlick eta/. (1980). 
Specific radioactivity (SRA) = 3H-Phe (dpm/g) 
Phe (l.tmol/g) 
Phe in dpm/g = Max. AUC Nle x dpm Phe 
AUC Nle weight of the tissue injected (g) 
Phe in ~.tmol/g = AUC Phe x 11mol Nle in sample 
AUC Nle weight of the tissue injected (g) 
Ks (%/d)= SRA of tissue bound protein x 
SRA of tissue free AA 
AUC- area under the curve 
dpm- disintegrations p er minute 
100 
Time between 3H-Phe injection and 
tissue freezing in days 
Max. AUC Nle - the maximum AUC of norleucine among samples in a set; this 
was used to correct for loss of sample during processing to determine dpm 
recovery 
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3.8 Muco-protein (mucin) synthesis 
This method was adapted from Nichols & Bertolo (2008) and Faure et a/. 
(2002). Mucin synthesis was measured for the ileum, colon and stomach 
samples. 
Protease digestion 
Approximately 300 mg of tissue was homogenized for 45 sin 2 mL of ice-cold 
SO mM Tris (pH 7.5) using a Polytron homogenizer at 30% . A solution 
containing 20 mg of Flavourzyme (a fungal complex of exopeptidases and 
endoproteases; Novozymes) was added to the homogenate and left to 
incubate under agitation in a 37°C water bath overnight. After 18 h, the 
enzymatic activity of Flavourzyme was stopped by placing the homogenate 
on ice for 10 min. Guanidium hydrochloride and dithiothreitol were added to 
4 M and 10 mmol/L concentrations, respectively, and the mixture was left at 
room temperature for 2 h under agitation. Finally, 25 mM iodoacetamide was 
added to the homogenate and left overnight at room temperature under 
agitation. 
Gravity gel filtration, dialvsis and radioactivity measurement 
Mucins were purified by gravity gel filtration chromatography using columns 
(POlO columns, BioRad) filled with 10 mL of Sepharose CL-48 resin (Sigma, 
wet bead diameter 40-165 ~-tm). The resin was equilibrated with 20 mL (or 
two times the volume of the column) of 0.05 M Tris/HCI buffer, pH 7.5 
containing 2M guanidinium hydrochloride (38.21 g GuHCI in 500 mL of 0.05 
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M Tris). One mL of homogenate was loaded onto the columns and eluted as 
the first fraction. Another 11 fractions were eluted separately in the void 
volume of the column by adding 1 mL of 0.05 M Tris/HCl buffer, pH 7.5 
containing 2 M guanidinium hydrochloride each time. 
Homogenate samples from each tissue (ileum, colon and stomach) were 
measured from piglets with the lowest, medium and highest threonine 
intakes. The muco-protein-containing fractions were dialyzed against 
deionized water for 48 h at 4°C using Spectra/Par molecular porous 
membrane tubing (12,000-14,000 molecular weight cutoff; Fisher Scientific). 
Initially, fractions were run on SDS-PAGE in order to identify the fractions 
from the column with mucin (described below). From those results, the first 
5 fractions were pooled for each tissue and radioactivity in 1 mL of the 
pooled fractions was measured using a liquid scintillation counter with 5 mL 
of Scintiverse. 
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Sodium dodecvl sulfate polyacrylamide gel electrophoresis (SDS-PAGEJ and 
PAS staining 
The following reagents were prepared. 
1.5 M (pH 8.8) 18.2 g/100 mL; adjust pH with HCI 
Tris-HCI 
1.0 M (pH 6.8) 12.1 g/100 m L; adjust pH with HCI 
10% Sodium dodecyl sulfate (SDS) 10 g/100 mL 
80% glycerol 80 g/100 mL 
1 M dithiothreitol (OTT) 1.545 g/10 mL 
1.5% ammonium persulfate (APS) 0.15 g/10 mL 
Stacking gel and resolving gel were prepared using the recipe below. 
Stacking gel Separating gel 
(4%) (7.5%) 
Deionized water 3.34 mL 3.1 mL 
30% Acrylamide 0.665 mL 1.875 mL 
1.0 M Tris-HCI (pH 6.8) 0.57 mL -
1.5 M Tris-HCI (pH 8.8) - 1.9 mL 
10% SDS 45 IlL 75 11L 
1.5% APS 330 IlL 500 IlL 
Tetram ethylethylenediamine (TEMED) 5 11L 5 IlL 
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Three 11L of 80% glycerol and 2 11L of OTT were mixed with 20 11L of each 
fraction and boiled for 3 min. Twenty 11L of boiled fractions and 7 11L of 
thawed molecular weight marker were applied to SOS-PAGE. Mucins were 
electrophoresed for 30 min at 10 rnA and then for 2 h at 20 rnA. Proteins in 
gels were r emoved and immediately stained with periodic acid/Schiffs 
reagent (PAS). 
Calculations 
Phenylalanine tracer incorporation into mucin was calculated for ileum, 
colon and stomach as dpm per milligram tissue per day and dpm per gram of 
protein per day. 
3.9 Threonine dehydrogenase activity 
TOG catalyzes the oxidation of L-threonine, yielding 2-amino-3-oxobutyric 
acid (2-amino-3-ketobutyrate), which is then decarboxylated to give 
aminoacetone or glycine and acetyl CoA when TOG is coupled w ith 2-amino-
3-oxobutyrate CoA ligase (or aminoacetone synthetase). The TOG activity is 
measured as the rate of aminoacetone formation at 533 nm. This method was 
adapted from Le Floc'h eta!. (1994). 
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The following reagents and buffers were prepared. 
0.2 M Tris 24.22 g/L 
0.15 M KCl 11.2 g/L 
0.5 M L-threonine 59.55 g/L 
25 mM Nicotinamide adenine 
dineucleotide (NAD) 
16.58 g/L 
3 mM aminoacetone 33 mg/100 mL 
0.5 M 41.02 g/L 
Sodium acetate 
3M 246.09 g/L 
1 N NaOH 40 g/L 
Acetylacetone 
3 M Trichloracetic acid (TCA) 490.24 g/L 
1 g dimethylaminobenzaldehyde (DMAB) 
Ehrlich Reagent + 8 mL 70% perchloric acid (PCA) + 
50 mL glacial acetic acid 
Buffer 1 0.2 M Tris + 0.15 M KCl pH 7.6 (with HCl) 
Buffer 2 0.2 M Tris pH 8.4 
Preparation o[tissue homogenate 
Approximately 1 g of tissue (liver and mid jejunum) was homogenized in 5 
mL of ice-cold Buffer 1. The homogenate was kept on ice for the duration of 
assay. The amount of homogenate to use in the assay was determined by 
conducting a homogenate dilution curve using a r ange of 5 to 100 j.!L; the 
final homogenate concentration used was within the linear portion of this 
curve. 
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Determination ofthe activity ofTDG 
The standards of aminoacetone with concentrations of 0, 75, 150, 300, 450, 
600 ~M were prepared as in Table 3.2 and run in duplicate. 
The reaction mixture was prepared in triplicate for the samples and in 
duplicate for controls as in Table 3.3. 
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Table 3.2: Reaction mixture for the standards of aminoacetone 
Aminoacetone 3 mM Aminoacetone Water Buffer 2 25 mM NAD 
h1M) (JlL) (JlL) (JlL) (JlL) 
0 0 200 500 100 
75 25 175 500 100 
150 50 150 500 100 
300 100 100 500 100 
450 150 50 500 100 
600 200 0 500 100 
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Table 3.3: Reaction mixture for the samples and controls of TOG assay 
Sample (J.LL) Control (J.LL) 
Buffer 2 500 500 
NAD 25 mM 100 100 
Homogenate 20 0 
Water 180 200 
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After a 5 min pre-incubation at 37°C, 200 111 of 0.5 M L-threonine was added 
to the samples and the controls (instead 200 111 of water was added to the 
standards in order to correct the volume) and the final mixture was 
incubated at 37°( for 10 min. The reaction was stopped by adding 1 mL of 3 
M TCA and centrifuged for 5 min at SOOOxg. 
Assa o aminoacetone 
One mL of supernatant was mixed with 250 mL of 0.5 M Na acetate and 150 
mL of 1 N NaOH. One hundred 11L of this mixture was taken and mixed with 
400 11L of 3 M sodium acetate (pH 4.6) and SO 11L of acetylacetone. The 
mixture was kept 10 min at 100°( and then let to cool on ice. After adding 
500 111 of Ehrlich's reagent, samples were incubated for 6 - 20 min at room 
temperature, and aminoacetone formation was measured at 553 nm. 
Calculations 
The concentration of aminoacetone formed (C) in 11moljmL was calculated 
by linear regression using the standard curve. The average concentration of 
the controls was subtracted from the average sample concentration and the 
protein concentration of the liver homogenate was identified from the Biuret 
assay. Activity per gram of tissue, activity per milligram of protein, total 
activity and activity per kilogram of body weight were calculated using the 
following equations. 
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Activity per g of tissue = 
(Jlmoljmin/g tissue) 
Activity by mg of protein = 
(~tmoljminjmg protein) 
(C x initial volume of homogenate) 
(incubation x portion of x weight of 
time homogenate used ground tissue) 
c 
(incubation x portion of 
time homogenate used 
x protein cone. of 
homogenate) 
Total Activity (Jlmoljmin) =Activity per g of tissue x weight of the liver 
Activity per kg of body weight (Jlmoljminjkg) = total activity 
body weight of the animal 
3.10Total tissue protein analysis using Biuret method 
Biuret reagent was prepared by dissolving 1.59 g of CuS04.5HzO in -500 mL 
deionized water; a nd adding 6 g of sodium potassium tartrate and 300 mL of 
10% NaOH with constant swirling. Then, the reagent was made up to 1 L w ith 
deionized water. 
The reaction mixture was prepared in individual tubes by adding th e order of 
deoinized water, 10 mg/mL of bovine serum albumin (BSA) or tissue sample 
and 5% sodium deoxycholic acid (DOC) as in Table 3.4. Tissue samples for 
t he total protein analysis were taken from the tissue bound AA preparations 
after solubilizing the re-suspended pellets in section 3.7. Th erefore, 1 M 
NaOH used to re-suspend the pellet was used to prepare the reaction mixture 
for the reagent blank. 
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Table 3.4: Reaction mixture for the BSA standards and samples 
Water BSAjsamplejNaOH DOC 
(~L) (~L) (~L) 
Blank 800 0 200 
BSA 10 790 10 (BSA) 200 
BSA 20 780 20 (BSA) 200 
BSA 30 770 30 (BSA) 200 
BSA 50 750 50 (BSA) 200 
Tissue Sample 750 50 (sample) 200 
Reagent blank 750 50 (NaOH) 200 
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Reaction mixtures were incubated at room temp for 10 min and 4 mL of the 
Biuret reagent was added to each tube. After 30 min at room temperature, 
the absorbance was read at 550 nm. Total protein was expressed as 
milligram of total protein per gram of tissue. 
3.11Statistical analyses 
Individual tissue dietary threonine requirements were identified using 
breakpoint analysis using one-slope, dual linear regression and quadratic fit. 
Then the best-fit model comparison was done by considering highest 
adjusted R2, R2 and lowest CV /RMSE/BIC/ AIC/ A!Cc. All these analyses were 
done in SAS version 9.0 and significance level was maintained at 5%. 
Individual tissue dietary threonine requirements were described as mean ± 
SE. 
Whole body threonine requirement was identified using plasma threonine 
response curve (plasma threonine concentration vs dietary threonine intake) 
with breakpoint analysis using one-slope, dual linear regression. This 
analysis was done in SAS version 9.0 and significant level was maintained at 
5%. 
Pearson Product Moment Correlations were calculated for the individual 
plasma amino acids vs plasma threonine concentrations. 
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Chapter 4 : RESULTS 
4.1 Health and performance of the animals 
All 20 Yucatan miniature piglets (age: 15 ± 1.1 days; body weight: 3.14 ± 0.30 
kg) were apparently healthy at the time of surgery and up to the time of the 
introduction of the experimental diet 5 days later (3.87 ± 0.35 kg); during the 
first 5 days of complete diet, pigs experienced an average rate of weight gain 
of 188 gjd, indicating normal weight gain throughout the study comparable 
to sow-fed piglets in this herd. They actively played with the toys provided 
and only 4 animals had transient diarrhea for a maximum of one day at day 2-
3, which was considered negligible. 
4.2 Plasma amino acid profile after experimental diet 
The plasma amino acid profile was analyzed after providing the 24-h 
experimental diet with different threonine levels (Appendix 1). Plasma 
threonine concentrations increased significantly with dietary threonine 
intakes greater than 3.0 g/100 g amino acid (Figure 4.1). Plasma 
concentrations of glycine, histidine, methionine and serine were all positively 
correlated w ith dietary threonine intakes; in contrast, plasma 3-methyl 
histidine was negatively correlated with dietary threonine and plasma 
tryptophan appeared to demonstrate a breakpoint response (Appendix 1). 
According to the Pearson Product Moment Correlation, only plasma glycine (r 
= 0.695; p = 0.0014) and serine (r = 0.702; p = 0.0008) concentrations were 
positively correlated with plasma threonine concentrations (Appendix 2). 3-
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Methyl histidine concentration, which reflects muscle protein breakdown, 
was constant across plasma threonine concentrations. 
The plasma threonine concentration response curve (Figure 4.1) over 
increasing dietary threonine intakes follows a breakpoint model. Plasma 
threonine concentrations are low and constant when threonine is below 
requirement because extra threonine is immediately incorporated into 
protein. Above requirement, extra threonine accumulates in the plasma pool 
as it is transported to the liver for oxidation (Bertolo eta/., 2005). Therefore, 
the plasma threonine breakpoint of 3.04 ± 0.60 g/100 g AA reflects the whole 
body requirement. This value is consistent with the threonine requirement of 
8 d old piglets identified by the indicator amino acid oxidation technique, i.e. 
2.8 ± 0.6 g/100 g AA (Bertolo eta/., 1998). 
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4.3 Individual tissue dietary threonine requirements and maximal 
fractional rate of protein synthesis 
The rates of fractional protein synthesis (Ks) using breakpoint analysis in 
non-mucus producing tissues (Figure 4.2) such as kidney, liver, 
gastrocnemius muscle and longissimus dorsi muscle, as well as mucus 
producing tissues (Figure 4.3) like lung, stomach, proximal jejunum, mid 
jejunum, ileum and colon, were plotted against different levels of dietary 
threonine intakes. 
All breakpoints were analyzed using one-slope j dual linear regression and 
quadratic fit models. One-slope, dual linear regression was selected as the 
best model considering highest adjusted R2 , R2 and lowest 
CV /RMSE/BIC/ AIC/ AICc; the results are presented in Figures 4.2 and 4.3. 
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Breakpoints were identified in non-mucus producing tissues (kidney, liver 
and muscle) and some of the mucus producing tissues (lung and colon). The 
other mucus producing tissues (stomach, proximal jejunum, mid-jejunum, 
ileum) did not have discernible breakpoints and with the exception of the 
ileum, the data were not different across threonine intakes, suggesting the 
data were at plateau (p>0.05). This suggests that for these tissues, the 
breakpoints might have existed at a dietary threonine level lower than the 
lowest threonine level fed, i.e. < 0.5 g/100 g AA. 
Of the tissues with breakpoints (Figure 4.2 and 4.3), lung, gastrocnemius 
muscle and colon had dietary threonine requirements that were lower than 
the whole body threonine requirement identified by plasma threonine 
response curve. Liver, longissimus dorsi muscle and kidney all had 
breakpoints with SE that overlapped the whole body threonine requirement 
SE and so were not considered different (Figure 4.4). 
The dietary threonine requirement of proximal and mid-jejunum and 
stomach were considered lowest and less than 0.5 g/100 g AA. The lowest 
observed breakpoint requirement was for colon (1.36 ± 0.29 g/100 g AA) 
followed by gastrocnemius muscle (1.76 ± 0.23 g/100 g AA), lung (1.95 ± 0.14 
g/100 g AA), liver (2.45 ± 0.60 g/100 g AA), longissimus dorsi muscle (2 .99 ± 
0.50 g/100 g AA) and then kidney (3.81 ± 0.97 g/100 g AA) . 
65 
After reaching the maximal fractional rate of protein synthesis at the 
breakpoint, the rate of fractional protein synthesis (Ks) follows a plateau. For 
data with a significant breakpoint, the plateau was regressed with a forced 
slope of zero; for data without a breakpoint, all data were linearly regressed 
but only ileum had a slope different than zero (Figure 4.5). 
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4.4 Dietary threonine required to maximize muco-protein synthesis 
The results for mucin isolation are consistent with those of Faure et a/. 
(2002), indicating that high molecular weight muco-proteins have only 
slightly migrated into the separating gel (Figure 4.6), and mucin was eluted 
primarily in the first three fractions. Therefore, the first five fractions were 
pooled to analyze mucin content. 
Dietary threonine required to maximize mucin synthesis in ileum and colon 
was 4.54 ± 1.50 g/100 g AA and 3.20 ± 4.70 g/100 g AA, respectively (Figure 
4.7), whereas, data for stomach did not have a breakpoint. Therefore, it was 
assumed that stomach needs less than 0.5 g/100 g AA of dietary threonine to 
maximize its muco-protein synthesis. 
After reaching the maximal fractional rate at the breakpoint, muco-protein 
synthesis reached a plateau. The maximal amount of muco-protein synthesis 
(y value at the breakpoint) in ileum is 47.53 dpm Phejmg of tissue and 4 7.26 
dpm Phejmg of tissue for the colon; interestingly, the maximal fractional rate 
for stomach was similar at around 42 dpm Phe/ mg of tissue. 
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Figure 4.6: SDS-PAGE analysis of fractions 1-5 (20 IlL) eluted from the 
Sepharose CL-4B column. Only ileum and colon of the piglet with the 
high est th reonine intake are displayed. 1, 2, 3, 4, 5 indicate the fractions 
elu ted from the column with the order of elution; M indica tes the marker. 
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4.5 Liver and gut threonine dehydrogenase (TDG) activity 
Dietary threonine that is not incorporated into protein is oxidized to glycine 
or ketobutyrate. Therefore, increased dietary threonine intake could 
potentially induce threonine catabolism and potentially mask the true 
breakpoint. In other words, increased threonine oxidation could limit 
availability of dietary threonine for protein synthesis. Hence, TOG activity, 
the main enzyme involved in threonine catabolism in pigs, was measured in 
order to ensure that the dietary threonine intake is directly proportional to 
protein synthesis. 
In vivo, catabolism depends on the amount of active enzyme, but also on the 
availability of threonine for the enzyme itself. This means, plasma 
concentration as well as threonine transport in the tissue are the main factors 
controlling the flux of threonine catabolism through the TOG pathway. Liver 
is the main site of threonine catabolism and >80% of threonine is catabolized 
by hepatic TOG. Therefore, activity of TOG in liver was also plotted against 
dietary threonine, plasma threonine, and liver free threonine levels. 
The TOG assay was conducted under the optimal conditions using 100 11M 
threonine as the substrate. However, tissue free threonine in the piglets of 
this study was <0.5 11M, indicating enzyme's capacity is much higher than the 
in vivo availability of threonine for oxidation. Therefore, 100% threonine in 
the liver of the sampled piglets would be catabolized by TOG. 
71 
No studies have been done to identify TOG activity in the gut and in order to 
compare gut TOG activity with the liver, gut TOG activity was also measured 
using three samples of the mid jejunum. 
Liver maximal TOG activity did not change across plasma, liver free or dietary 
threonine concentrations (Figure 4.8), indicating TOG catabolism of 
threonine does not change with intake over the short adaptation period of 
this study. The mean TOG activity per gram of wet liver was 8.56 ± 1.35 
IJ.molfmin/g and this value is comparable to the liver TOG activity identified 
in a previous study using the same analytical method, i.e. 5.62 llmol/ min/g 
(Le Floc'h & Seve, 2005) . TOG activity of the jejunum was 0.25-1.15 
IJ.mol/min/g and this value was considered negligible (0.4-2.7% of total 
activity in both gut and liver) when compared with the liver (97.3-99.6% of 
total activity). 
The tissues of the GI tract require threonine to sustain their own functions 
and growth, whereas the liver is mainly involved in the catabolism of excess 
amino acid. 
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Figure 4.8: Liver TDG specific activity per gram of tissue. Each point 
represents data from individual pigs; data are regressed using linear 
regression. TF: tissue-free. 
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Chapter 5 GENERAL DISCUSSION AND CONCLUSION 
Results of the current study indicate that dietary threonine is preferentially 
utilized for protein synthesis in the gastrointestinal tract tissues of piglets. 
Interestingly, the mucin-producing tissues have been reported to have a high 
obligatory requirement for threonine due to their abundance of threonine-rich 
muco-proteins (Mantle & Allen, 1981). Therefore, protein synthesis in these 
tissues is maintained when dietary threonine is limiting. If neonates are on a 
marginal dietary threonine intake, then muscle growth and the functions of other 
vital tissues are likely compromised at the expense of maintenance of the mucus 
layer. Moreover, TDG activity is not markedly affected by changes in the level of 
24-h dietary threonine intake indicating that dietary threonine reflects threonine 
available for protein synthesis. 
The plasma threonine response (Figure 4.1) was typical of that observed in other 
experiments designed to determine amino acid requirements (Mitchell eta/., 1968; 
Young eta/., 1972). Plasma threonine concentrations were low and constant when 
dietary threonine was deficient and increased with dietary threonine intake after 
the breakpoint. 
Threonine is critical for the production of gut mucins (Vlaardingerbroek et a!., 
2011) and the mucus layer provides a first line of defense to multiple molecules, 
toxins and pathogens (Allen et a!., 1984; Valle, 2012). A novel and important 
finding from the present study is that the protein synthesis in mucin-producing 
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tissues (Figure 4.3) does not change with lower dietary threonine content, unlike 
in non-mucin-producing tissues (Figure 4.2), suggesting that mucin-producing 
tissues extract limiting threonine at th e expense of other tissues for protein 
synthesis, especially at lower dietary threonine intakes. Therefore, mucin-
producing tissues will not be affected by deficient dietary th r eonine. Because the 
small intestine extracts dietary threonine on first pass (Le Floc'h & Seve, 2005; 
Stoll et a!., 1998a; Stoll et a!., 1998b ), it is anatomically positioned to extract 
dietary threonine first to meet its own requirements. This in turn decreases 
threonine availability for the other vital organs and muscle when di etary threonine 
is defici ent. Moreover, in addition to the likely first pass extraction of limited 
dietary threonine, the intestine also likely extracts arterial threonine to maintain 
protein synthesis; it is also possible that the intestinal tissues are simply more 
effici ent at protein turnover during dietary deficiency so little threonine is lost 
and/or more is r ecycled. 
The concept that dietary threonine extraction by the small intestine may reduce 
threonine availability for the other tissues when young piglets are fed a diet 
marginally de fi cient in threonine has been discussed before (Hamard et al., 2009). 
Similar to our data, Hamard et a/. (2009) found that moderate reductions in 
dietary threonine supply to piglets did not modify the fractional rates of mucosal 
prote in synthesis in the proximal jejunum, the ileum and the colon. Similarly, in 
adult rats, the mucosal protein synthesis (Schaart et a/., 2005; van der Schooler et 
a!., 2002) was not impai red in the small and large intestines whatever th e level of 
threonine deficiency (Faure eta/., 2005) . Contradictorily, a previous study (Wang 
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eta!., 2007) indicated that the fractional synthesis rate of small intestinal mucosal 
protein and mucins of young pigs was reduced by an imbalanced intake of dietary 
threonine. The response of protein synthesis to a threonine deficient diet could be 
influenced by several factors such as the tissue and organ, the degree of threonine 
deficiency and the animal species and age (Hamard eta!., 2009). 
Both small intestine and stomach did not have discernible breakpoints. Moreover, 
for the ileum, the data were either slightly increasing or at plateau. To help clarify 
the response of these tissues, we decided to determine the response of mucin 
synthesis to dietary threonine to see if the most abundant threonine-rich protein is 
more sensitive to dietary threonine supply. Although protein synthesis in the 
ileum did not have a breakpoint over the dietary threonine range, the mucin 
synthesis response did display a distinct breakpoint. Moreover, the breakpoint for 
colonic mucin was much greater than that for total protein ynthesis. These data 
suggest that these intestinal tissues are sensitive to dietary threonine supply and 
that mucin protein synthesis specifically is reduced with lower dietary threonine. 
It is possible that the reduced mucin synthesis is responding to luminally delivered 
threonine whereas total protein synthesis is maintained from arterial threonine 
extraction. Whether other secretory proteins are similarly affected by limiting 
luminal threonine is unknown but it appears individual proteins might be 
prioritized within intestinal tissues in the face of threonine deficiency. Similar to 
breakpoint analysis for total protein, the stomach did not have a breakpoint when 
purified mucin was analyzed; these data suggest that perhaps the stomach is 
particularly resistant to changes in dietary threonine. The maxim al synthesis rates 
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of total protein and mucin were similar to those in small intestinal tissues, which 
suggests that the stomach does utilize significant amounts of threonine, but 
apparently does not respond to dietary threonine in the same manner as the lower 
GIT. 
Unlike non-mucin-producing tissues, protein synthesis of intestines and stomach 
do not respond to dietary threonine suggesting these tissues maintain synthesis of 
total protein at the expense of other tissues when dietary threonine is deficient. 
The muscle and kidney are the most sensitive organs for protein synthesis w hen 
dietary threonine is limiting, as these tissues maximized protein synthesis at 
higher dietary threonine levels compared with other tissues. Therefore, the growth 
and functions of the kidney and muscle are most likely to be compromised at even 
moderately deficient dietary threonine intake. However, the reason why the 
kidney is the most sensitive organ to dietary threonine intake is unknown; 
although it should be noted that the difference in the rate of kidney protein 
synthesis from plateau and the lowest rate was smaller ( -25%) than that in other 
tissues (-50%). In the current study, dietary deficiency of threonine results in 
lower rates of protein synthesis in skeletal muscle and liver. Wang eta/., (2007) 
found that young pigs fed a 0.37% true ileal digestible threonine (TIDT) diet had a 
20% lower weight gain compared with pigs fed control (0.74 % TIDT) diets. This 
was considered due to impaired muscle growth due to the threonine deficient diet 
but they also suggested that the rate of protein synthesis in skeletal muscle is more 
responsive to changes in dietary intake of nutri ents, including ami no acids, than in 
the liver (Wang et a/., 2007). In anoth er study (Hamard et a/., 2009), protein 
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metabolism in the small intestine seemed to be preserved while the liver appeared 
more sensitive to a moderate dietary threonine deficiency than the other body 
compartments, such as colon and muscle. In the current study, the liver was more 
sensitive to dietary threonine compared to all GJT tissues but less so than kidney 
and longissimus dorsi muscle. 
The gastrocnemius muscle is a very powerful superficial pennate muscle that is in 
the back part of the lower leg, and is involved in standing, walking, running and 
jumping, whereas, the longissimus is the muscle lateral to the semispinalis, and 
involved in respiratory movements as well as helping to move the neck. The fast 
and slow muscle fibres alter the activity of myosin ATPase, which is directly 
related to the intrinsic speed of contraction of a muscle, and the number of fibres 
low in myosin ATPase activity increases with growth (Davies, 1972). All these 
differences result in different distribution of the muscle fibre types; for example, 
the gastrocnemius contains about 50% slow twitch oxidative fibres (Edgerton et 
a!., 1975) that use oxidative metabolism to generate ATP, whereas longissimus has 
30.5% slow twitch fibres (Davies, 1972). There may be differences in amino acid 
composition of fast and slow-twitch muscle fibres and so it may be possible to have 
differences in the amino acid composition of the muscle types. This might help 
explain why the two muscle groups responded differently to dietary threonine 
content. Alternatively, gastrocnemius muscle is more active in young pigs 
compared with longissimus dorsi and therefore blood circulation may be higher in 
gastrocnemius muscle to meet its increased demand for oxygen and other 
substrates during movements. Therefore, it is also possible that the gastrocnemius 
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muscle extracts more dietary threonine via the blood than longissimus dorsi, 
perhaps explaining why the latter muscle is more sensitive to diminishing 
threonine supply. 
When comparing maximal fractional rates of protein synthesis (Figure 4.5), the 
highest maximal fractional rate was found for the liver and lowest for the muscle. 
This was hypothesized, as liver is a highly metabolically active organ, whereas 
muscle is least metabolically active. The second highest maximal synthesis rate 
was for the small intestine indicating its importance as a metabolically active 
organ. 
In pigs, TOG is the main enzyme involved in threonine catabolism (Kidd & Kerr, 
1996; Le Floc'h eta/., 1995; Le Floc'h eta/., 1996) and it mainly occurs in the liver 
(Le Floc'h eta/., 1995; Le Floc'h eta/., 1997). However, extrahepatic threonine 
oxidation may also be associated with the decrease in total oxidation when dietary 
supply of threonine is reduced (Le Floc'h eta/., 1995).1fTOG oxidation is increased 
as dietary threonine is increased, then dietary threonine may not be available for 
protein synthesis, which might change the shape of the breakpoint curves. For 
example, if most of each increment of additional dietary threonine is oxidized by 
the gut and liver, then the protein synthesis curve would increas e only slowly, if at 
all. So to address this potential confounder, we measured TOG activity in gut and 
liver but found no differences across dietary threonine content. 
79 
As in previous observations (Le Floc'h et a/., 1995; Wang et a/., 2007), plasma 
concentrations of glycine, a product of oxidation of threonine in mammals, 
including pigs, was positively correlated with plasma threonine concentrations 
(results not shown; r = 0.695; p = 0.0014). However, Wang eta/. (2007) identified 
that further increases in dietary threonine beyond 0.74% true ileal digestible 
threonine did not additionally increase plasma glycine, suggesting a limit in 
threonine degradation via the hepatic TOG pathway. However, in our study, 
deficient diets were only fed for 24 hours, so induction of oxidative enzymes might 
be more limited than in chronic feeding studies; but threonine oxidation to glycine 
also takes place in extrahepatic tissues and probably only partly in the liver (Le 
Floc'h eta/., 1995). Indeed, although we did not detect any correlation of hepatic 
TOG activity with dietary threonine, plasma glycine was positively correlated with 
dietary threonine intake perhaps suggesting there is some extrahepatic oxidation 
induction as dietary threonine is increased. 
Le Floc'h & Seve (2005) reported that the specific TOG activity in liver and 
pancreas was 5.62 and 1.46 llmol/min/g, respectively, compared with 8.56 ± 1.35 
11mol/min/g found for liver in the current study. TOG activity has not been 
detected in the small intestine in pigs (Le Floc'h & Seve, 2005; Le Floc'h eta/., 
1997; Wu, 1998) and our current data confirm this conclusion of negligible specific 
TOG activity ( < 2.78% of the hepatic activity, based on grams of tissue) in the 
intestine. Moreover, the activity of TOG in the gut relative to the hepatic activity 
identified in the current study is even lower than that of pancreas ( < 10%), brain 
(10%) and kidney (30%) in pigs identified by previous studies (Green & Elliott, 
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1964 in Le Floc'h eta/., 1995). Therefore, intestinal threonine catabolism does not 
help explain why intestinal tissues had no breakpoint across dietary threonine 
intakes. In other words, the first-pass dietary threonine extracted by the intestine 
is mostly available for protein synthesis. Pancreas oxidation could be more 
responsive to a decrease in plasma threonine concentration when compared with 
liver (Le Floc'h eta/., 1995). However, the current study did not investigate TOG 
activity in the pancreas, as we hypothesized that given the enormous size 
difference between gut and pancreas, gut TOG activity would be more significant. 
Le Floc'h eta/. (1995) also could not find any effect of dietary threonine on liver 
TOG specific activity in pigs. Moreover, when the dietary supply of essential amino 
acids is low, in vivo oxidation of these acids seems to be limited to preserve their 
use for protein synthesis (Le Floc'h et a/., 1995). Also, threonine seems to be poorly 
taken up by the liver compared with other amino acids in pigs (Rerat eta/., 1992), 
and therefore, one of the reasons for a relatively low hepatic oxidation of threonine 
could be a lower uptake (Le Floc'h eta/., 1995). Further, according to Michaelis 
Menten kinetic parameters, the hepatic enzyme in pigs has high value of Km, i.e. 5 
mM (Tressel et a/., 1986) and therefore, threonine oxidation into glycine should 
occur at a level dependent on tissue threonine concentration (Le Floc'h et a/., 
1995). However, liver TOG activity did not change according to the change in 
plasma threonine concentration or liver tissue free threonine level in our study, 
further indicating dietary threonine is mainly used for the protein synthesis and 
was not catabolized via the TOG pathway (Figure 4.8). Moreover, it is important to 
note that in the current study, the hepatic free threonine availability (i.e., <0.5 j..lM 
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is much lower than the hepatic enzyme capacity. Therefore capacity exceeded 
available threonine and any changes within our study parameters would not be 
measurable without tracer kinetics applications. 
Conclusion 
By analyzing breakpoints in individual tissues, we were able to evaluate the 
partitioning of dietary threonine to target organs for protein synthesis. In other 
words, as threonine is removed from the diet, we were able to determine which 
tissues reduced protein synthesis thereby sparing threonine for other tissues. It 
also helped further define the requirement of dietary threonine to achieve optimal 
growth as marginal dietary threonine intake can adversely affect growth and 
functions of certain vital tissues except the gut. It is obvious that not all tissues 
require the same dietary threonine level and our data help explain why growth is 
limited before intestinal function. Dietary threonine is obviously very important to 
maintain the mucus layer of the gut, which is the first barrier protection against 
p thogens and anti-nutritional dietary components. By determining individual 
dietary threonine "requirements" by breakpoint, we can estimate the amount of 
dietary threonine necessary to maintain protein synthesis in each tissue. In the 
future, it would be interesting to investigate the changes to these dietary threonine 
"requirements" of individual tissues in the presence of different mucin 
secretagogues such as fibre. Such data would help define the therapeutic levels of 
threonine necessary to maintain function in specific tissues. 
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APPENDIX 1: Plasma amino acid profile against dietary threonine 
Figures 1 to 20: Each point represents data from individual pigs; data are 
regressed using simple linear regression or dual linear regression (for Fig. 1 
and 16) with breakpoint analysis. Dashed lines in Fig. 1 and 16 represent 
their break points. Fig. 18 has a sigmoidal curve. Regression co-efficient (R2) 
and p-value for each linear regression are shown. 
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APPENDIX 2: Plasma glycine and serine against plasma threonine 
Figures 1 and 2: Each point represents data from individual pigs; data are 
regressed using simple linear regression. Pearson Product Moment 
Correlation co-efficient (r) and p-value for each cor relation are shown. 
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